Emilie Faivre Selected Research

Emilie Faivre Research Topics

12	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2009
4	Inflammation (Inflammations) 01/2013 - 12/2010
3	Tauopathies 01/2023 - 01/2019
3	Memory Disorders (Memory Loss) 01/2021 - 01/2018
3	Cognitive Dysfunction 01/2021 - 10/2015
2	Neuroinflammatory Diseases 11/2021 - 01/2018
2	Amyloid Plaque 01/2013 - 04/2011
2	Type 2 Diabetes Mellitus (MODY) 04/2011 - 12/2009
1	Neoplasms (Cancer) 11/2022
1	Neuralgia (Stump Neuralgia) 11/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2021
1	Dementia (Dementias) 11/2021
1	Amyloidosis 01/2021
1	Splenomegaly 01/2021
1	Spinocerebellar ataxia 21 06/2020
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Seizures (Absence Seizure) 01/2019
1	Insulin Resistance 05/2012
1	Obesity 05/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Body Weight (Weight, Body) 04/2011
1	Colitis 12/2010

4	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023 - 01/2018
4	Amyloid (Amyloid Fibrils)IBA 11/2021 - 04/2011
3	Peptides (Polypeptides)IBA 11/2021 - 05/2012
3	IncretinsIBA 01/2013 - 12/2009
2	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 12/2018
2	tau Proteins (tau Protein)IBA 11/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 06/2020 - 11/2019
2	Caffeine (No Doz)FDA LinkGeneric 01/2019 - 01/2018
2	Hormones (Hormone)IBA 01/2013 - 05/2012
2	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2012 - 12/2009
2	Insulin (Novolin)FDA Link 04/2011 - 12/2009
1	Cisplatin (Platino)FDA LinkGeneric 11/2022
1	istradefyllineIBA 11/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Serine (L-Serine)FDA Link 01/2020
1	Complement C1q (C1q Complement)IBA 11/2019
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2019
1	ChemokinesIBA 10/2015
1	Neuroprotective AgentsIBA 01/2013
1	gastric inhibitory polypeptide (3-42)IBA 05/2012
1	Glucose (Dextrose)FDA LinkGeneric 05/2012
1	Pro(3)- glucose-dependent insulinotropic polypeptideIBA 01/2012
1	Liraglutide FDA Link 04/2011
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2011
1	SodiumIBA 01/2011
1	Dextrans (Dextran)FDA Link 01/2011
1	Therapeutic UsesIBA 12/2010
1	IntegrinsIBA 12/2010
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2009

1	Drug Therapy (Chemotherapy) 11/2022
1	Biological Therapy 11/2021